Add to a list

Inactive Instrument

SL Therapeutics, Inc. Share Price

A258540

KR7258540004

Pharmaceuticals

on all subscriptions*

Last days

Enjoy this offer

* See conditions under "Our services"

Latest news : SL Therapeutics, Inc.

13/10/22	StemLab Inc. announced that it has received KRW 1.5000006 billion in funding	CI
27/07/22	StemLab Inc. announced that it expects to receive KRW 1.5000006 billion in funding	CI
03/03/21	StemLab Inc. announced that it has received KRW 4 billion in funding	CI
23/02/21	StemLab Inc. announced that it expects to receive KRW 4 billion in funding	CI
26/10/20	StemLab Inc. announced that it has received KRW 5 billion in funding from DAYLI Partners Co., Ltd., IBK Capital Corporation, Blueotus Co., Ltd., DB Asset Management Co., Ltd.	CI
20/06/19	StemLab Inc. announced that it expects to receive KRW 5 billion in funding from DAYLI Partners Co., Ltd., IBK Capital Corporation, Blueotus Co., Ltd., DB Asset Management Co., Ltd. and another investor	CI
28/03/19	StemLab Inc. announced that it has received KRW 1.5 billion in funding	CI
13/03/19	StemLab Inc. announced that it expects to receive KRW 1.5 billion in funding	CI

More news

Press Releases: SL Therapeutics, Inc.

24/02/23

In volo con Leonardo: the new work orientation pathway of the STEMLab project

More press releases

Managers and Directors: SL Therapeutics, Inc.

Manager	Title	Age	Since
Jong-Seong Choi CEO	Chief Executive Officer	62	18/10/2022
Seung-Kwon Yoo PSD	President	61	28/03/2021
Jung-Il No AUD	Comptroller/Controller/Auditor	65	11/08/2024

Director	Title	Age	Since
Seung-Kwon Yoo BRD	Director/Board Member	61	-
Jong-Seong Choi BRD	Director/Board Member	62	-
Min-Woo Park BRD	Director/Board Member	58	28/03/2022

More insiders

SL Therapeutics Inc, formerly Stem Lab Inc, is a Korea-based company principally engaged in the manufacture and sale of biopharmaceuticals. The Company is principally engaged in the development, research, manufacture and sale of biopharmaceuticals such as stem cell culture mediums, stem cell treatment as well as others.

Employees

Sector

Pharmaceuticals

More about the company

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SL THERAPEUTICS, INC.	+61.97%	+49.35%	-	-	403K
REGENERON PHARMACEUTICALS, INC.	+0.11%	-3.67%	+15.66%	-20.62%	62.28B
UCB	-2.33%	+2.72%	+65.54%	+216.16%	60.59B
SAMSUNG BIOLOGICS CO.,LTD.	+0.70%	+29.50%	+29.50%	+29.50%	39.55B
CSL LIMITED	-1.84%	+6.09%	-55.86%	-62.24%	36.8B
BIOGEN INC.	+0.05%	+2.41%	+53.12%	-33.31%	29.53B
INCYTE CORPORATION	+0.65%	+6.01%	+60.19%	+76.64%	21.68B
MODERNA, INC.	+0.54%	+5.21%	+87.14%	-60.40%	19.8B
INNOVENT BIOLOGICS, INC.	+1.70%	+6.08%	-3.24%	+128.87%	16.96B
SWEDISH ORPHAN BIOVITRUM AB	-0.46%	-1.49%	+51.56%	+99.00%	16.16B
Average	+6.09%	+3.05%	+33.74%	+41.51%	33.71B
Weighted average by Cap.	-0.45%	+2.95%	+31.10%	+46.00%

SL Therapeutics, Inc. Share Price

Stocks

A258540

KR7258540004

Pharmaceuticals

Latest news : SL Therapeutics, Inc.

Press Releases: SL Therapeutics, Inc.

Quotes and Performance

Managers and Directors: SL Therapeutics, Inc.

Biopharmaceuticals

Company Profile